Edition:
India

Eiger BioPharmaceuticals Inc (EIGR.OQ)

EIGR.OQ on NASDAQ Stock Exchange Global Market

11.90USD
9:30pm IST
Change (% chg)

$-0.10 (-0.83%)
Prev Close
$12.00
Open
$12.00
Day's High
$12.12
Day's Low
$11.90
Volume
2,732
Avg. Vol
37,441
52-wk High
$18.00
52-wk Low
$7.50

Chart for

About

Eiger BioPharmaceuticals, Inc., formerly Celladon Corporation, is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of products for the treatment of orphan diseases. Its pipeline includes Sarasar (lonafarnib) for hepatitis delta virus (HDV), exendin (9-39) for severe... (more)

Overall

Beta: 2.57
Market Cap(Mil.): $107.52
Shares Outstanding(Mil.): 8.37
Dividend: --
Yield (%): --

Financials

BRIEF-Eiger Biopharmaceuticals Prices Previously Announced Public Offering Of Common Stock

* EIGER BIOPHARMACEUTICALS PRICES PREVIOUSLY ANNOUNCED PUBLIC OFFERING OF COMMON STOCK

24 May 2018

BRIEF-Eiger Biopharmaceuticals Announces Proposed Public Offering Of Common Stock

* EIGER BIOPHARMACEUTICALS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK

24 May 2018

BRIEF-Eiger Biopharmaceuticals Sees Phase 3 D-Livr Trial Starting In Second Half 2018​

* EIGER BIOPHARMACEUTICALS ANNOUNCES POSITIVE GUIDANCE FOLLOWING FDA MEETING ON HEPATITIS DELTA VIRUS REGISTRATION PROGRAM

21 Mar 2018

Earnings vs. Estimates